Hillrom and Welch Allyn are a part of Baxter.
23px-Flag_baxterUS.svg.png  United States
text.skipToContent text.skipToNavigation
  1. Baxter Catalog
  2. Pharmaceuticals
  3. Premixed Medications
  4. Clindamycin Injection USP in 5% Dextrose, 300 mg /50 mL in GALAXY Plastic Container. Liquid Premix.
Due to missing information on your Hillrom Direct account, you are not able to add items to the cart or continue with the checkout process. Please contact our customer support team for further assistance by clicking on "contact us".
MP_logo
Clindamycin Injection USP in 5% Dextrose, 300 mg /50 mL in GALAXY Plastic Container. Liquid Premix.
Item Number: 2G3452
GTIN:  00303383410504
GTIN-CS:  50303383410509
Clindamycin Injection USP in 5% Dextrose, 300 mg/50 mL in GALAXY Plastic Container. Liquid Premix. Please refer to full Prescribing Information, including Boxed Warning for Clostridium difficile-associated diarrhea (CDAD). NDC 0338-3410-50.
print-icon Print email-icon Email
Email PDF ✕
Specifications

Product Characteristics

Trademark GALAXY is a trademark of Baxter International Inc., or its subsidiaries.
Volume 50.0 ml
Shelf Life from Manufacture 18 months
Concentration 6 mg/mL
Container Type GALAXY
Containes Preservative No
Diluent Dextrose
Dosage Form Liquid
Polyethlene Lined No
Rx Only Yes
Storage Recommendations It is recommended that GALAXY plastic containers be stored at 20° to 25°C (68° to 77°F)[see USP Controlled Room Temperature]. Avoid temperatures above 30°C.
Strength 300 mg/50 mL

Carton

Units per Case 24.0
Carton Weight 3.33 lb.
Carton Length 11.94 in.
Carton Width 5.88 in.
Carton Height 2.5 in.
Carton Volume 0.1 fc

Reimbursement Information

HCPCS Code HCPCS Description
J0736 Injection, clindamycin phosphate, 300mg
A4216 STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML
Medication Delivery Reimbursement Hotline 888-338-0001

Information Source : CMS

Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Ordering Information
Item Number 2G3452
Sales Unit case
GTIN 00303383410504
GTIN-CS 50303383410509
National Drug Code 0338341050
Documents

Documentation

PDF

Package Insert Link

     203052r1